Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Pancreatitis
Studies from M.G.H. Besselink et al further understanding of acute pancreatitis
April 6th, 2008
According to recent research from Netherlands, " Infectious complications and associated mortality are a major concern in acute pancreatitis. Enteral administration of probiotics could prevent infectious complications, but convincing evidence is scarce." "Our aim was to assess the effects of probiotic prophylaxis in patients with predicted severe acute pancreatitis. In this multicentre randomised, double-blind, placebo-controlled trial, 298 patients with predicted severe acute pancreatitis (Acute Physiology and Chronic Health Evaluation [APACHE II] score >= 8, Imrie score >= 3, or C-reactive protein >150 mg/L) were randomly assigned within 72 h of onset of...
Source: Pharma Investments, Ventures & Law Weekly (2008-04-06)
|
